West Pharmaceutical Services, Inc. Stock

Equities

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:01 2024-05-03 pm EDT 5-day change 1st Jan Change
365 USD -0.93% Intraday chart for West Pharmaceutical Services, Inc. +1.27% +3.66%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 3.01B Sales 2025 * 3.28B Capitalization 26.59B
Net income 2024 * 567M Net income 2025 * 672M EV / Sales 2024 * 8.63 x
Net cash position 2024 * 617M Net cash position 2025 * 1.02B EV / Sales 2025 * 7.8 x
P/E ratio 2024 *
47.8 x
P/E ratio 2025 *
40.9 x
Employees 10,600
Yield 2024 *
0.26%
Yield 2025 *
0.3%
Free-Float 96.39%
More Fundamentals * Assessed data
Dynamic Chart
Declaration of Voting Results of the West Pharmaceutical Services Inc CI
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc CI
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423 MT
Health Care Drops Amid Mixed Earnings -- Health Care Roundup DJ
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023. CI
West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised MT
Transcript : West Pharmaceutical Services, Inc., Q1 2024 Earnings Call, Apr 25, 2024
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400 MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29 MT
West Pharmaceutical Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
West Pharmaceutical Services, Inc. Reaffirms Earnings Guidance for the Full Year 2024 CI
West Pharmaceutical Services, Inc. Announces Third Quarter 2024 Dividend, Payable on August 7, 2024 CI
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says RE
More news

Latest transcript on West Pharmaceutical Services, Inc.

1 day-0.93%
1 week+1.27%
Current month+2.11%
1 month-7.36%
3 months-8.20%
6 months+8.96%
Current year+3.66%
More quotes
1 week
352.76
Extreme 352.76
372.79
1 month
352.76
Extreme 352.76
396.75
Current year
325.74
Extreme 325.735
413.70
1 year
310.42
Extreme 310.42
415.73
3 years
206.19
Extreme 206.19
475.35
5 years
113.04
Extreme 113.04
475.35
10 years
39.11
Extreme 39.11
475.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 15-04-23
Director of Finance/CFO 55 18-06-20
Chief Tech/Sci/R&D Officer 52 18-02-25
Members of the board TitleAgeSince
Director/Board Member 66 11-01-31
Chief Executive Officer 55 15-04-23
Director/Board Member 63 16-09-11
More insiders
Date Price Change Volume
24-05-03 365 -0.93% 451,107
24-05-02 368.5 +1.38% 445,558
24-05-01 363.4 +1.66% 579,085
24-04-30 357.5 +0.87% 697,386
24-04-29 354.4 -1.67% 516,095

Delayed Quote Nyse, May 03, 2024 at 04:00 pm EDT

More quotes
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
365 USD
Average target price
397.1 USD
Spread / Average Target
+8.80%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW